YTHDC1 lactylation regulates its phase separation to enhance target mRNA stability and promote RCC progression
- PMID: 40680722
- DOI: 10.1016/j.molcel.2025.06.017
YTHDC1 lactylation regulates its phase separation to enhance target mRNA stability and promote RCC progression
Abstract
The hypoxic and lactate-enriched microenvironment of renal cell carcinoma (RCC) provides favorable conditions for aberrant lysine lactylation (Kla). However, the functional role and mechanistic basis of Kla in RCC progression remain elusive. Here, we showed an elevated global Kla level in human RCC tissues and cells, which promoted RCC malignancy. Through lactylome analysis of human RCC cells under hypoxia-mimicking conditions, we found that the m6A reader YT521-B homology (YTH) domain-containing 1 (YTHDC1) is modified by Kla at K82. YTHDC1K82la, mediated by p300 under hypoxia, promotes RCC malignancy both in vitro and in vivo. Mechanistically, YTHDC1K82la increases YTHDC1 phase separation, leading to the expansion of nuclear condensates and safeguarding oncogenic transcripts BCL2 and E2F2 from degradation by the poly A-tail exosome targeting (PAXT)-exosome complex in human RCC cells. Our results demonstrated that augmented Kla advances RCC progression by modulating phase separation and thereby regulating the stability of YTHDC1 target genes.
Keywords: BCL2; E2F2; YTHDC1; lactylation; phase-separated condensate; renal cancer.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.J Cancer Res Clin Oncol. 2019 Mar;145(3):573-588. doi: 10.1007/s00432-018-2808-0. Epub 2018 Dec 3. J Cancer Res Clin Oncol. 2019. PMID: 30511250 Free PMC article.
-
Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.J Cancer Res Clin Oncol. 2018 Jan;144(1):39-52. doi: 10.1007/s00432-017-2527-y. Epub 2017 Oct 9. J Cancer Res Clin Oncol. 2018. PMID: 28993942 Free PMC article.
-
AURKB/CDC37 complex promotes clear cell renal cell carcinoma progression via phosphorylating MYC and constituting an AURKB/E2F1-positive feedforward loop.Cell Death Dis. 2024 Jun 18;15(6):427. doi: 10.1038/s41419-024-06827-y. Cell Death Dis. 2024. PMID: 38890303 Free PMC article.
-
Unraveling m6A RNA methylation: From epitranscriptomics to therapeutic frontiers in renal cell carcinoma.Cell Signal. 2025 Oct;134:111952. doi: 10.1016/j.cellsig.2025.111952. Epub 2025 Jun 20. Cell Signal. 2025. PMID: 40545111 Review.
-
The role of c-Met in prognosis and clinicopathology of renal cell carcinoma: Results from a single-centre study and systematic review.Urol Oncol. 2017 Aug;35(8):532.e15-532.e23. doi: 10.1016/j.urolonc.2017.03.027. Epub 2017 Apr 18. Urol Oncol. 2017. PMID: 28427859
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous